Endocrinology
From the Journals
GLP-1 Receptor Agonists Don’t Raise Thyroid Cancer Risk
Researchers compared data from 145,410 patients who initiated GLP-1 RAs and 291,667 patients initiating dipeptidyl peptidase 4 (DPP4) inhibitors...
Latest News
Study Highlights Some Semaglutide-Associated Skin Effects
Patients who received 50 mg oral semaglutide weekly reported a higher incidence of altered skin sensations, in the review of 22 articles.
Latest News
Is It Possible to Reverse Osteoporosis?
Genetics, exercise, and other factors impact bone health in younger years, and therapies may be able to improve or slow osteoporosis.
Conference Coverage
Hormones and Viruses Influence Each Other: Consider These Connections in Your Patients
Infections with coronaviruses or other infectious agents like influenza can significantly worsen metabolic status, diabetes, and other endocrine...
Latest News
Long-Term Calcium and Vitamin D: Cancer Deaths Down, CVD Deaths Up in Older Women?
Physicians need to take a nuanced approach to supplementation based on benefits and risks for each postmenopausal patient.
Latest News
Vitamin D Supplement Protects Insulin-Producing Cells in T1D
For newly-diagnosed T1D patients, treatment with high doses of a vitamin D analog may extend disease remission.
Feature
Does worsening metabolic syndrome increase the risk of developing cancer?
Elevated trajectories of metabolic syndrome were associated with an elevated overall cancer risk.
Latest News
Do Organophosphate Esters Increase Thyroid Disease Risk?
Chemicals found in flame retardants were linked to increased risk for thyroid disease, study finds.
News from the FDA/CDC
First Denosumab Biosimilar Approved in Two Different Formulations
Denosumab-bddz was also granted interchangeability status, which allows pharmacists to substitute the biosimilar for the reference product without...
Latest News
Is Adrenal Fatigue a Real Condition?
“The problem is not the adrenals — it is the exposure to stress in the brain.”
From the Journals
Osteoporosis Drug Denosumab May Confer Lower Risk for Diabetes
The lower risk for diabetes associated with continued denosumab use in older adults added new evidence to consider when choosing an osteoporosis...